α1-抗胰蛋白酶缺乏症成人肝胆表型研究
Pi*ZZ基因型肝纤维化/肝硬化aOR=21.7,原发性肝癌aOR=44.5;Pi*MZ与Pi*SZ亦与肝病相关;Pi*SS除ALT轻度升高外无其他肝胆异常。男性、年龄≥50岁、肥胖和糖尿病与显著肝纤维化相关。
要点
- Pi*ZZ基因型肝纤维化/肝硬化风险显著增高(aOR=21.7),原发性肝癌风险极高(aOR=44.5)
- Pi*MZ基因型与肝纤维化/肝硬化(aOR=1.7)和胆石症(aOR=1.3)风险轻度增加相关
- 男性、年龄≥50岁、肥胖和糖尿病是显著肝纤维化的相关因素
核心结论
- 研究明确了主要AATD基因型的肝胆表型及其对肝肿瘤的易感性,为循证建议和个体化肝脏监测提供依据。
主要发现
- 在英国生物银行参与者中,Pi*ZZ个体肝酶值最高,肝纤维化/肝硬化aOR=21.7(8.8-53.7),原发性肝癌aOR=44.5(10.8-183.6)。
- Pi*MZ基因型受试者肝酶轻度升高,肝纤维化/肝硬化aOR=1.7(1.2-2.2),胆石症aOR=1.3(1.2-1.4)。
- Pi*SS基因型个体丙氨酸氨基转移酶轻度升高,但无其他肝胆异常。
- Pi*SZ参与者肝酶较高,肝纤维化/肝硬化aOR=3.1(1.1-8.2),原发性肝癌aOR=6.6(1.6-26.9)。
- 多国队列证实Pi*ZZ和Pi*SZ的肝纤维化负担更高;男性、年龄≥50岁、肥胖和糖尿病与显著肝纤维化相关。
临床怎么用
- 对Pi*ZZ和Pi*SZ基因型个体应进行个体化肝脏监测,包括肝纤维化和肝癌筛查。
- 对Pi*MZ基因型个体需关注肝纤维化和胆石症风险,尤其合并代谢危险因素时。
- 男性、年龄≥50岁、肥胖和糖尿病是显著肝纤维化的相关因素,应加强风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Alpha-1 antitrypsin deficiency (AATD) is a common, potentially lethal inborn disorder caused by mutations in alpha-1 antitrypsin (AAT). Homozygosity for the 'Pi*Z' variant of AAT (Pi*ZZ genotype) causes lung and liver disease, whereas heterozygous 'Pi*Z' carriage (Pi*MZ genotype) predisposes to gallstones and liver fibrosis. The clinical significance of the more common 'Pi*S' variant remains largely undefined and no robust data exist on the prevalence of liver tumours in AATD. DESIGN: Baseline phenotypes of AATD individuals and non-carriers were analysed in 482 380 participants in the UK Biobank. 1104 participants of a multinational cohort (586 Pi*ZZ, 239 Pi*SZ, 279 non-carriers) underwent a comprehensive clinical assessment. Associations were adjusted for age, sex, body mass index, diabetes and alcohol consumption. RESULTS: Among UK Biobank participants, Pi*ZZ individuals displayed the highest liver enzyme values, the highest occurrence of liver fibrosis/cirrhosis (adjusted OR (aOR)=21.7 (8.8-53.7)) and primary liver cancer (aOR=44.5 (10.8-183.6)). Subjects with Pi*MZ genotype had slightly elevated liver enzymes and moderately increased odds for liver fibrosis/cirrhosis (aOR=1.7 (1.2-2.2)) and cholelithiasis (aOR=1.3 (1.2-1.4)). Individuals with homozygous Pi*S mutation (Pi*SS genotype) harboured minimally elevated alanine aminotransferase values, but no other hepatobiliary abnormalities. Pi*SZ participants displayed higher liver enzymes, more frequent liver fibrosis/cirrhosis (aOR=3.1 (1.1-8.2)) and primary liver cancer (aOR=6.6 (1.6-26.9)). The higher fibrosis burden was confirmed in a multinational cohort. Male sex, age ≥50 years, obesity and the presence of diabetes were associated with significant liver fibrosis. CONCLUSION: Our study defines the hepatobiliary phenotype of individuals with the most relevant AATD genotypes including their predisposition to liver tumours, thereby allowing evidence-based advice and individualised hepatological surveillance.
引用
- Fromme M, Schneider CV, Pereira V, et al. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency. Gut. 2021. PMID: 33632708. doi:10.1136/gutjnl-2020-323729
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。